NPI: 1619918075 · YAZOO CITY, MS 39194 · Critical Access Hospital · NPI assigned 06/09/2006
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/ CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 06/09/2006 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 42,381 | $1.62M |
| 2019 | 41,417 | $1.78M |
| 2020 | 36,223 | $1.34M |
| 2021 | 44,767 | $1.62M |
| 2022 | 57,891 | $1.81M |
| 2023 | 54,896 | $1.95M |
| 2024 | 37,812 | $1.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,464 | 10,369 | $2.16M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 16,934 | 14,104 | $2.15M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,888 | 4,922 | $1.24M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,916 | 4,642 | $484K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,936 | 5,095 | $446K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,794 | 8,070 | $398K |
| G0378 | Hospital observation service, per hour | 949 | 698 | $380K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,389 | 2,189 | $306K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,895 | 2,353 | $253K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,254 | 2,758 | $252K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,075 | 2,464 | $248K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,800 | 1,514 | $247K |
| 71045 | Radiologic examination, chest; single view | 6,535 | 5,285 | $238K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6,515 | 5,380 | $224K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 15,602 | 6,652 | $191K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,578 | 3,922 | $189K |
| 71046 | Radiologic examination, chest; 2 views | 4,456 | 3,736 | $187K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 924 | 777 | $182K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,218 | 6,311 | $155K |
| 80053 | Comprehensive metabolic panel | 18,210 | 13,892 | $139K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 22,988 | 16,904 | $118K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,568 | 3,380 | $117K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,648 | 2,341 | $90K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,434 | 2,912 | $85K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,223 | 4,322 | $74K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 529 | 141 | $67K |
| 83880 | 3,330 | 2,490 | $63K | |
| 73560 | 1,264 | 1,092 | $55K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,338 | 2,951 | $45K |
| 36415 | Collection of venous blood by venipuncture | 21,632 | 15,571 | $45K |
| 84484 | 6,024 | 4,161 | $41K | |
| 81001 | 15,650 | 12,710 | $37K | |
| 74018 | 751 | 641 | $34K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,023 | 1,698 | $33K |
| 81025 | 5,457 | 4,564 | $33K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 435 | 326 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,413 | 2,091 | $31K |
| 73630 | 669 | 561 | $29K | |
| 80061 | Lipid panel | 2,917 | 2,558 | $28K |
| 73030 | 656 | 549 | $25K | |
| 80305 | 2,413 | 2,044 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,836 | 2,823 | $18K |
| 36600 | 681 | 530 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,031 | 2,543 | $16K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 74 | 65 | $16K |
| 73130 | 310 | 284 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 564 | 478 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 563 | 478 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,392 | 2,011 | $15K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 175 | 141 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 827 | 657 | $14K |
| 83690 | 2,933 | 2,370 | $14K | |
| 87040 | 2,292 | 1,101 | $13K | |
| 82803 | 772 | 575 | $13K | |
| 83605 | 1,954 | 1,536 | $11K | |
| 87807 | 1,029 | 890 | $11K | |
| 83735 | 2,695 | 2,024 | $11K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 202 | 182 | $11K |
| 87186 | 1,945 | 1,473 | $10K | |
| 73610 | 205 | 180 | $10K | |
| 72100 | 191 | 141 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 129 | 117 | $10K |
| A9270 | Non-covered item or service | 3,571 | 2,106 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 117 | 107 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 165 | 145 | $8K |
| 71250 | 99 | 89 | $7K | |
| 82150 | 1,352 | 1,139 | $7K | |
| 87081 | 1,593 | 1,241 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 378 | 285 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,954 | 3,404 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,627 | 3,844 | $6K |
| 82553 | 698 | 511 | $6K | |
| 74019 | 85 | 75 | $6K | |
| 85379 | 1,043 | 857 | $6K | |
| 85610 | 2,388 | 1,840 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 165 | 148 | $5K |
| 82550 | 923 | 695 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 72 | 66 | $5K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 20 | 12 | $4K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 98 | 62 | $4K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 16 | 15 | $4K |
| 70486 | 32 | 29 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 27 | 26 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 169 | 150 | $3K |
| 96376 | 1,064 | 563 | $3K | |
| 85730 | 822 | 690 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 16 | 12 | $3K |
| 73502 | 46 | 40 | $2K | |
| 87070 | 201 | 161 | $1K | |
| 86900 | 49 | 30 | $1K | |
| 72131 | 13 | 13 | $1K | |
| 86592 | 389 | 279 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,653 | 1,243 | $1K |
| 86677 | 91 | 70 | $827.95 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,496 | 1,272 | $791.73 |
| 87205 | 187 | 156 | $619.67 | |
| 73110 | 16 | 12 | $581.18 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,714 | 2,899 | $567.36 |
| 84703 | 64 | 53 | $447.84 | |
| 96367 | 14 | 13 | $437.85 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 245 | 196 | $391.83 |
| 74021 | 16 | 14 | $382.21 | |
| 86901 | 49 | 30 | $375.45 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 32 | 25 | $365.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,641 | 2,020 | $347.98 |
| 85027 | 147 | 115 | $309.07 | |
| J2060 | Injection, lorazepam, 2 mg | 41 | 39 | $238.85 |
| 86803 | 14 | 12 | $232.30 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 117 | 74 | $221.20 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 516 | 207 | $217.12 |
| 87088 | 36 | 23 | $203.29 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,563 | 1,348 | $172.04 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 479 | 375 | $165.24 |
| 87077 | 36 | 21 | $152.94 | |
| 86850 | 31 | 15 | $86.20 | |
| J1940 | Injection, furosemide, up to 20 mg | 403 | 240 | $76.45 |
| 84550 | 32 | 30 | $70.97 | |
| 82009 | 13 | 12 | $44.77 | |
| J7050 | Infusion, normal saline solution, 250 cc | 61 | 40 | $32.68 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 17 | 15 | $30.13 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 62 | 47 | $20.33 |
| J2704 | Injection, propofol, 10 mg | 111 | 94 | $18.29 |
| J1170 | Injection, hydromorphone, up to 4 mg | 264 | 160 | $12.02 |
| J7510 | Prednisolone oral, per 5 mg | 819 | 719 | $5.67 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 26 | 13 | $2.77 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 140 | 112 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 32 | 27 | $0.00 |
| 90715 | 62 | 55 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 17 | 12 | $0.00 |
| 94760 | 108 | 66 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 145 | 116 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 37 | 25 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 12 | 12 | $0.00 |
| 36416 | 71 | 23 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 15 | 14 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 18 | 14 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 17 | 14 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 21 | 12 | $0.00 |